Coordination Confined Silver-Organic Framework for High Performance Electrochemical Deionization.

Silver (Ag) is deemed a promising anode material for capacitive deionization (CDI) due to its high theoretical capacity and efficient selectivity to Cl-. However, the strong volume change during the conversion reaction significantly undermines the cycling performance of the Ag electrode. Additionally, achieving well-dispersed Ag in the active matrix is challenging, as Ag electrodes prepared by conventional thermal reduction tend to agglomerate. Herein, the organic linker confinement strategy is proposed, applying metal-organic framework (MOF) chemistry between Ag nodes and organic ligands to construct Ag-based MOF. The uniform dispersion of Ag at the molecular level, confined in the organic matrix, efficiently enhances the utilization of active sites, and strengthens the interfacial stability of Ag. Consequently, the Ag-MOF for the CDI anode exhibits an excellent Cl- removal capacity of 121.52 mg g-1 at 20 mA g-1 in 500 mg L-1 NaCl solution, and a high Ag utilization rate of 60.54%. After 100 cycles, a capacity retention of 96.93% is achieved. Furthermore, the Cl- capture mechanism of Ag-MOF is elucidated through density functional theory (DFT) calculations, ex situ XRD, ex situ Raman and XPS. This ingenious electrode design can offer valuable insights for the development of high-performance conversion electrodes for CDI applications.

Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation.

BACKGROUND: Enterprise stent was approved for the treatment of wide-necked intracranial aneurysms. However, it has been widely used in the endovascular treatment of intracranial artery stenosis, which is still controversial. The purpose of this study was to evaluate the safety and efficiency of the Enterprise stent in the endovascular treatment of intracranial artery stenosis disease. METHODS: We conducted a retrospective case series of 107 patients with intracranial artery stenosis who received Enterprise stent implantation at Nanjing Drum Tower Hospital from January 2020 to December 2022. The rates of recanalization, perioperative complications, in-stent restenosis at 3-12 months and stroke recurrence were assessed for endovascular treatment. RESULTS: A total of 107 individuals were included in this study, 88 were followed up, and 19 (17.8%) patients were lost to follow-up. The operation success rate was 100%, During the procedure,4（3.7%）patients had vasospasm, and 2(1.9%) patients showed symptomatic bleeding. The overall perioperative complication rate was 5.6%, including 2.8% distal artery embolism, 0.9% in-stent thrombosis, and 1.9% symptomatic bleeding. 88 (82.2%) patients were followed up from 3 to 12 months, of whom 12 (13.6%) had in-stent restenosis, 4 (4.7%) recurrent strokes and 2 died of pulmonary infection caused by COVID-19. Patients were divided into 3 groups according to the cerebral artery, including the middle cerebral artery group, internal carotid artery group, and vertebrobasilar artery group. CONCLUSIONS: In this study, the placement of the Enterprise stent in patients with symptomatic non-acute intracranial stenosis was successful. However, the occurrence of periprocedural and long-term complications after stenting remains of high concern.

In the View of Electrons Transfer and Energy Conversion: The Antimicrobial Activity and Cytotoxicity of Metal-Based Nanomaterials and Their Applications.

The global pandemic and excessive use of antibiotics have raised concerns about environmental health, and efforts are being made to develop alternative bactericidal agents for disinfection. Metal-based nanomaterials and their derivatives have emerged as promising candidates for antibacterial agents due to their broad-spectrum antibacterial activity, environmental friendliness, and excellent biocompatibility. However, the reported antibacterial mechanisms of these materials are complex and lack a comprehensive understanding from a coherent perspective. To address this issue, a new perspective is proposed in this review to demonstrate the toxic mechanisms and antibacterial activities of metal-based nanomaterials in terms of energy conversion and electron transfer. First, the antimicrobial mechanisms of different metal-based nanomaterials are discussed, and advanced research progresses are summarized. Then, the biological intelligence applications of these materials, such as biomedical implants, stimuli-responsive electronic devices, and biological monitoring, are concluded based on trappable electrical signals from electron transfer. Finally, current improvement strategies, future challenges, and possible resolutions are outlined to provide new insights into understanding the antimicrobial behaviors of metal-based materials and offer valuable inspiration and instructional suggestions for building future intelligent environmental health.

Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation.

AIMS: The role of cilostazol after intracranial or extracranial artery stent implantation is still unclear. Therefore, we designed this trial to explore the efficacy and safety of cilostazol in this particular population. METHODS: In this retrospective study, patients were divided into the cilostazol or clopidogrel group by the antiplatelet therapy received after artery stent implantation. The primary efficacy endpoint was ischemic stroke. Bleeding events and other antiplatelet drug-related adverse reactions (ADRs) were also recorded. Neurological function prognosis was evaluated by the modified Rankin Scale (mRS) after discharge. RESULTS: A total of 156 patients were enrolled; 56 underwent intracranial artery stenting, 95 underwent extracranial artery stenting, and 5 underwent intracranial combined with extracranial artery stenting. Any stroke and bleeding events in the hospital of the two groups were comparable (P=0.38, P=0.34, respectively). The incidence of stroke recurrence tended to be lower in the cilostazol group, although not significant (cilostazol vs. clopidogrel, 1.35% vs. 4.88%, P=0.25). There was a significant difference of any bleeding events between the two groups (cilostazol vs. clopidogrel, 5.41% vs. 20.73%, P=0.02). During follow-up, we did not observe an apparent increase of ADRs in the cilostazol group (cilostazol vs. clopidogrel, palpitation 4.05% vs. 2.44%, P=0.58; gastrointestinal discomfort events 8.11% vs. 12.20%, P=0.80). There were no differences between the two groups of neurological function prognosis (P=0.29). CONCLUSIONS: Cilostazol-based dual antiplatelet therapy could be recommended as an effective and safe therapy regimen among patients undergoing intracranial or extracranial artery stent implantation.

Selenium and nitrogen co-doped biochar as a new metal-free catalyst for adsorption of phenol and activation of peroxymonosulfate: Elucidating the enhanced catalytic performance and stability.

Coupling of adsorption and advanced oxidation processes triggered by metal-free carbocatalysts is an appealing wastewater purification scheme. However, its practical application is challenging due to the unsatisfactory stability of conventional heteroatom-doped systems. Herein, we innovatively developed a simple and scalable biochemical strategy to synthesize selenium and nitrogen co-doped biochar (Se/N-BC) as a bifunctional catalyst of adsorption-oxidation. The Se/N-BC displays the highest efficiency of phenol (PE) degradation (99.2% of PE was removed within 5 min) with the lowest dosage of catalyst (0.1 g L-1) and peroxymonosulfate (PMS, 0.4 g L-1). More importantly, the Se/N-BC is not only universal in a wide pH range of 3.0-11.0 and complex ionic environment, but also possesses an excellent cycling stability. The Se/N co-doping induces a rapid cycle of adsorption-degradation for PE. The Se/N-BC acts as an "electron transfer bridge", guiding rapid electron transfer from PE to PMS to achieve high-efficient degradation. The Se/N co-doping facilitates the formation of graphitic N and unlocks the potential of adjacent C sites for PMS activation, consequently boost oxidation efficiency. In addition, the oxidation of catalyst is prevented due to the antioxidant properties of Se, which has been a primary concern either to regenerate adsorbate or to enhance degradation performance.

Biodeposited Nano-CdS Drives the In Situ Growth of Highly Dispersed Sulfide Nanoparticles during Pyrolysis for Enhanced Oxygen Evolution Reaction.

A novel, efficient, and stable graphene-based composite oxygen evolution reaction (OER) catalyst, BG@Ni/Ni3S2, was designed via high-specificity, low-cost biosynthesis and efficient electrostatic self-assembly. In the synthetic process, bacterial cells containing biodeposited CdS nanocrystals, graphene oxide (GO), and Ni2+ ions are assembled into a sandwich-type hybrid precursor. The nanosized sulfur source drives in situ sulfidation during pyrolysis, which induces the uniform formation and growth of Ni/Ni3S2 composite nanoparticles (NPs) on the graphene substrate. Benefiting from the high specific surface area and uniform distribution of NPs, the catalyst has a large number of exposed active sites and exhibits rapid mass transfer. In addition, the skeleton composed of a conductive carbon matrix and metallic Ni-Ni network ensures the excellent electron transfer during the OER, and the synergistic effect of Ni0 and Ni3S2 further optimizes the electronic structure and accelerates the OER kinetics. The dominant catalytic sites at the nanointerface between Ni0 and Ni3S2 provide favorable thermodynamic conditions for the adsorption of OER intermediates. As a result, BG@Ni/Ni3S2 exhibits efficient catalytic performance for the OER: the overpotential and Tafel slope are only 320 mV at 100 mA cm-2 and 41 mV dec-1, respectively. This work provides a novel understanding of the intrinsic activity of transition metal sulfide composites and a biological-based design for OER catalysts.